Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for BARHL1
Z-value: 3.07
Motif logo
Transcription factors associated with BARHL1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
BARHL1
|
ENSG00000125492.5 | BarH like homeobox 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| BARHL1 | hg19_v2_chr9_+_135458021_135458046 | -0.37 | 3.6e-02 | Click! |
Activity profile of BARHL1 motif
Sorted Z-values of BARHL1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr18_+_29171689 | 4.97 |
ENST00000237014.3
|
TTR
|
transthyretin |
| chr8_+_1993152 | 4.18 |
ENST00000262113.4
|
MYOM2
|
myomesin 2 |
| chr3_+_63428982 | 3.84 |
ENST00000479198.1
ENST00000460711.1 ENST00000465156.1 |
SYNPR
|
synaptoporin |
| chr14_+_32798462 | 3.77 |
ENST00000280979.4
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr13_-_114107839 | 3.76 |
ENST00000375418.3
|
ADPRHL1
|
ADP-ribosylhydrolase like 1 |
| chr5_+_140593509 | 3.65 |
ENST00000341948.4
|
PCDHB13
|
protocadherin beta 13 |
| chr13_+_30002741 | 3.61 |
ENST00000380808.2
|
MTUS2
|
microtubule associated tumor suppressor candidate 2 |
| chr11_+_27076764 | 3.46 |
ENST00000525090.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr14_+_32798547 | 3.46 |
ENST00000557354.1
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr8_+_1993173 | 3.44 |
ENST00000523438.1
|
MYOM2
|
myomesin 2 |
| chr4_-_186732892 | 3.44 |
ENST00000451958.1
ENST00000439914.1 ENST00000428330.1 ENST00000429056.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr9_-_112179990 | 3.38 |
ENST00000394827.3
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3 |
| chr8_+_79503458 | 3.34 |
ENST00000518467.1
|
PKIA
|
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
| chrX_+_46937745 | 3.28 |
ENST00000397180.1
ENST00000457380.1 ENST00000352078.4 |
RGN
|
regucalcin |
| chr4_-_186734275 | 3.20 |
ENST00000456060.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr11_+_27062272 | 3.19 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr4_-_186732048 | 3.15 |
ENST00000448662.2
ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr13_+_30002846 | 3.10 |
ENST00000542829.1
|
MTUS2
|
microtubule associated tumor suppressor candidate 2 |
| chrX_-_15333775 | 3.08 |
ENST00000480796.1
|
ASB11
|
ankyrin repeat and SOCS box containing 11 |
| chr4_-_186578674 | 3.08 |
ENST00000438278.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr6_+_53976211 | 2.98 |
ENST00000503951.1
|
MLIP
|
muscular LMNA-interacting protein |
| chr1_+_237205476 | 2.94 |
ENST00000366574.2
|
RYR2
|
ryanodine receptor 2 (cardiac) |
| chr6_+_53976235 | 2.92 |
ENST00000502396.1
ENST00000358276.5 |
MLIP
|
muscular LMNA-interacting protein |
| chr3_-_46608010 | 2.92 |
ENST00000395905.3
|
LRRC2
|
leucine rich repeat containing 2 |
| chr14_+_32964258 | 2.91 |
ENST00000556638.1
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr18_+_68002675 | 2.90 |
ENST00000584919.1
|
RP11-41O4.1
|
Uncharacterized protein |
| chr10_+_69865866 | 2.88 |
ENST00000354393.2
|
MYPN
|
myopalladin |
| chr12_-_22063787 | 2.85 |
ENST00000544039.1
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
| chr20_-_62129163 | 2.85 |
ENST00000298049.7
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr18_-_48351743 | 2.84 |
ENST00000588444.1
ENST00000256425.2 ENST00000428869.2 |
MRO
|
maestro |
| chr10_+_18629628 | 2.78 |
ENST00000377329.4
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
| chr4_+_69962185 | 2.74 |
ENST00000305231.7
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr6_+_53883708 | 2.71 |
ENST00000514921.1
ENST00000274897.5 ENST00000370877.2 |
MLIP
|
muscular LMNA-interacting protein |
| chr1_+_197237352 | 2.68 |
ENST00000538660.1
ENST00000367400.3 ENST00000367399.2 |
CRB1
|
crumbs homolog 1 (Drosophila) |
| chr10_-_115423792 | 2.64 |
ENST00000369360.3
ENST00000360478.3 ENST00000359988.3 ENST00000369358.4 |
NRAP
|
nebulin-related anchoring protein |
| chr12_-_11091862 | 2.63 |
ENST00000537503.1
|
TAS2R14
|
taste receptor, type 2, member 14 |
| chr8_-_82359662 | 2.60 |
ENST00000519260.1
ENST00000256103.2 |
PMP2
|
peripheral myelin protein 2 |
| chr12_-_71551652 | 2.57 |
ENST00000546561.1
|
TSPAN8
|
tetraspanin 8 |
| chr12_-_71551868 | 2.57 |
ENST00000247829.3
|
TSPAN8
|
tetraspanin 8 |
| chr3_+_35722487 | 2.54 |
ENST00000441454.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr9_-_93405352 | 2.52 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
| chr9_-_104249400 | 2.51 |
ENST00000374848.3
|
TMEM246
|
transmembrane protein 246 |
| chr7_-_81635106 | 2.51 |
ENST00000443883.1
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
| chr3_+_42190714 | 2.50 |
ENST00000449246.1
|
TRAK1
|
trafficking protein, kinesin binding 1 |
| chr4_+_169575875 | 2.50 |
ENST00000503457.1
|
PALLD
|
palladin, cytoskeletal associated protein |
| chr11_+_27062502 | 2.47 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr18_+_32455201 | 2.46 |
ENST00000590831.2
|
DTNA
|
dystrobrevin, alpha |
| chr19_+_18726786 | 2.46 |
ENST00000594709.1
|
TMEM59L
|
transmembrane protein 59-like |
| chr12_-_11287243 | 2.39 |
ENST00000539585.1
|
TAS2R30
|
taste receptor, type 2, member 30 |
| chr10_+_7745303 | 2.39 |
ENST00000429820.1
ENST00000379587.4 |
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
| chr2_+_101591314 | 2.38 |
ENST00000450763.1
|
NPAS2
|
neuronal PAS domain protein 2 |
| chrX_-_49056635 | 2.37 |
ENST00000472598.1
ENST00000538567.1 ENST00000479808.1 ENST00000263233.4 |
SYP
|
synaptophysin |
| chr2_-_44550441 | 2.36 |
ENST00000420756.1
ENST00000444696.1 |
PREPL
|
prolyl endopeptidase-like |
| chr10_-_93392811 | 2.34 |
ENST00000238994.5
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C |
| chr2_-_179672142 | 2.34 |
ENST00000342992.6
ENST00000360870.5 ENST00000460472.2 ENST00000589042.1 ENST00000591111.1 ENST00000342175.6 ENST00000359218.5 |
TTN
|
titin |
| chr6_-_136788001 | 2.31 |
ENST00000544465.1
|
MAP7
|
microtubule-associated protein 7 |
| chrM_+_10464 | 2.31 |
ENST00000361335.1
|
MT-ND4L
|
mitochondrially encoded NADH dehydrogenase 4L |
| chr4_-_65275162 | 2.29 |
ENST00000381210.3
ENST00000507440.1 |
TECRL
|
trans-2,3-enoyl-CoA reductase-like |
| chr14_-_94421605 | 2.29 |
ENST00000556062.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
| chr3_-_196242233 | 2.29 |
ENST00000397537.2
|
SMCO1
|
single-pass membrane protein with coiled-coil domains 1 |
| chr3_+_63428752 | 2.26 |
ENST00000295894.5
|
SYNPR
|
synaptoporin |
| chr6_+_53964336 | 2.26 |
ENST00000447836.2
ENST00000511678.1 |
MLIP
|
muscular LMNA-interacting protein |
| chr4_-_186570679 | 2.26 |
ENST00000451974.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr8_+_91803695 | 2.26 |
ENST00000417640.2
|
NECAB1
|
N-terminal EF-hand calcium binding protein 1 |
| chr3_-_149293990 | 2.23 |
ENST00000472417.1
|
WWTR1
|
WW domain containing transcription regulator 1 |
| chr4_-_182186182 | 2.23 |
ENST00000512547.1
|
RP11-665C14.2
|
RP11-665C14.2 |
| chr2_+_133874577 | 2.23 |
ENST00000596384.1
|
AC011755.1
|
HCG2006742; Protein LOC100996685 |
| chr10_-_50970322 | 2.21 |
ENST00000374103.4
|
OGDHL
|
oxoglutarate dehydrogenase-like |
| chr20_+_5892037 | 2.21 |
ENST00000378961.4
|
CHGB
|
chromogranin B (secretogranin 1) |
| chrX_-_15511438 | 2.21 |
ENST00000380420.5
|
PIR
|
pirin (iron-binding nuclear protein) |
| chr1_-_85930246 | 2.20 |
ENST00000426972.3
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
| chr14_+_100204027 | 2.12 |
ENST00000554479.1
ENST00000555145.1 |
EML1
|
echinoderm microtubule associated protein like 1 |
| chr7_-_82792215 | 2.09 |
ENST00000333891.9
ENST00000423517.2 |
PCLO
|
piccolo presynaptic cytomatrix protein |
| chr20_+_5892147 | 2.08 |
ENST00000455042.1
|
CHGB
|
chromogranin B (secretogranin 1) |
| chr6_-_135271219 | 2.08 |
ENST00000367847.2
ENST00000367845.2 |
ALDH8A1
|
aldehyde dehydrogenase 8 family, member A1 |
| chr5_+_78985673 | 2.08 |
ENST00000446378.2
|
CMYA5
|
cardiomyopathy associated 5 |
| chr2_+_11696464 | 2.08 |
ENST00000234142.5
|
GREB1
|
growth regulation by estrogen in breast cancer 1 |
| chr12_+_126107042 | 2.02 |
ENST00000535886.1
|
TMEM132B
|
transmembrane protein 132B |
| chr8_-_112039643 | 2.01 |
ENST00000524283.1
|
RP11-946L20.2
|
RP11-946L20.2 |
| chr5_-_149644944 | 2.01 |
ENST00000515758.1
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha |
| chr18_+_32398326 | 2.00 |
ENST00000269192.7
ENST00000591182.1 ENST00000597674.1 ENST00000556414.3 |
DTNA
|
dystrobrevin, alpha |
| chr6_+_30856507 | 1.99 |
ENST00000513240.1
ENST00000424544.2 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr20_+_32782375 | 1.99 |
ENST00000568305.1
|
ASIP
|
agouti signaling protein |
| chr12_-_120189900 | 1.98 |
ENST00000546026.1
|
CIT
|
citron (rho-interacting, serine/threonine kinase 21) |
| chr8_+_99076750 | 1.98 |
ENST00000545282.1
|
C8orf47
|
chromosome 8 open reading frame 47 |
| chr4_-_141348763 | 1.98 |
ENST00000509477.1
|
CLGN
|
calmegin |
| chr18_-_48346415 | 1.98 |
ENST00000431965.2
ENST00000436348.2 |
MRO
|
maestro |
| chr6_+_53883790 | 1.98 |
ENST00000509997.1
|
MLIP
|
muscular LMNA-interacting protein |
| chr7_-_135412925 | 1.97 |
ENST00000354042.4
|
SLC13A4
|
solute carrier family 13 (sodium/sulfate symporter), member 4 |
| chr1_+_47533160 | 1.95 |
ENST00000334194.3
|
CYP4Z1
|
cytochrome P450, family 4, subfamily Z, polypeptide 1 |
| chr2_+_166150541 | 1.94 |
ENST00000283256.6
|
SCN2A
|
sodium channel, voltage-gated, type II, alpha subunit |
| chr10_+_24755416 | 1.93 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
| chr2_-_68547061 | 1.92 |
ENST00000263655.3
|
CNRIP1
|
cannabinoid receptor interacting protein 1 |
| chr21_+_40824003 | 1.92 |
ENST00000452550.1
|
SH3BGR
|
SH3 domain binding glutamic acid-rich protein |
| chr1_-_163172625 | 1.92 |
ENST00000527988.1
ENST00000531476.1 ENST00000530507.1 |
RGS5
|
regulator of G-protein signaling 5 |
| chr1_+_100111580 | 1.92 |
ENST00000605497.1
|
PALMD
|
palmdelphin |
| chr13_-_114103443 | 1.91 |
ENST00000356501.4
ENST00000413169.2 |
ADPRHL1
|
ADP-ribosylhydrolase like 1 |
| chrM_+_10758 | 1.91 |
ENST00000361381.2
|
MT-ND4
|
mitochondrially encoded NADH dehydrogenase 4 |
| chr8_-_97247759 | 1.90 |
ENST00000518406.1
ENST00000523920.1 ENST00000287022.5 |
UQCRB
|
ubiquinol-cytochrome c reductase binding protein |
| chr11_-_118047376 | 1.90 |
ENST00000278947.5
|
SCN2B
|
sodium channel, voltage-gated, type II, beta subunit |
| chr1_-_60392452 | 1.90 |
ENST00000371204.3
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2 |
| chr4_+_78829479 | 1.90 |
ENST00000504901.1
|
MRPL1
|
mitochondrial ribosomal protein L1 |
| chr17_-_55911970 | 1.89 |
ENST00000581805.1
ENST00000580960.1 |
RP11-60A24.3
|
RP11-60A24.3 |
| chr3_+_26735991 | 1.89 |
ENST00000456208.2
|
LRRC3B
|
leucine rich repeat containing 3B |
| chr10_-_50970382 | 1.89 |
ENST00000419399.1
ENST00000432695.1 |
OGDHL
|
oxoglutarate dehydrogenase-like |
| chr1_-_68915610 | 1.89 |
ENST00000262340.5
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa |
| chr5_-_41261540 | 1.88 |
ENST00000263413.3
|
C6
|
complement component 6 |
| chr4_+_71600063 | 1.88 |
ENST00000513597.1
|
RUFY3
|
RUN and FYVE domain containing 3 |
| chr2_+_233527443 | 1.87 |
ENST00000410095.1
|
EFHD1
|
EF-hand domain family, member D1 |
| chr4_-_70361615 | 1.87 |
ENST00000305107.6
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4 |
| chr10_-_127505167 | 1.87 |
ENST00000368786.1
|
UROS
|
uroporphyrinogen III synthase |
| chr18_+_18943554 | 1.87 |
ENST00000580732.2
|
GREB1L
|
growth regulation by estrogen in breast cancer-like |
| chr5_+_43602750 | 1.86 |
ENST00000505678.2
ENST00000512422.1 ENST00000264663.5 |
NNT
|
nicotinamide nucleotide transhydrogenase |
| chr4_+_159131346 | 1.84 |
ENST00000508243.1
ENST00000296529.6 |
TMEM144
|
transmembrane protein 144 |
| chr5_-_11588907 | 1.84 |
ENST00000513598.1
ENST00000503622.1 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr9_+_108463234 | 1.84 |
ENST00000374688.1
|
TMEM38B
|
transmembrane protein 38B |
| chr10_-_69597915 | 1.83 |
ENST00000225171.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
| chr10_-_97321112 | 1.83 |
ENST00000607232.1
ENST00000371227.4 ENST00000371249.2 ENST00000371247.2 ENST00000371246.2 ENST00000393949.1 ENST00000353505.5 ENST00000347291.4 |
SORBS1
|
sorbin and SH3 domain containing 1 |
| chr11_+_27062860 | 1.83 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr15_-_45670717 | 1.82 |
ENST00000558163.1
ENST00000558336.1 |
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
| chr10_-_61899124 | 1.81 |
ENST00000373815.1
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
| chr4_-_186877502 | 1.81 |
ENST00000431902.1
ENST00000284776.7 ENST00000415274.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr18_+_32398400 | 1.81 |
ENST00000599844.1
|
DTNA
|
dystrobrevin, alpha |
| chr12_+_26348246 | 1.79 |
ENST00000422622.2
|
SSPN
|
sarcospan |
| chr3_+_186383741 | 1.79 |
ENST00000232003.4
|
HRG
|
histidine-rich glycoprotein |
| chr2_+_183943464 | 1.78 |
ENST00000354221.4
|
DUSP19
|
dual specificity phosphatase 19 |
| chr4_-_22444733 | 1.78 |
ENST00000508133.1
|
GPR125
|
G protein-coupled receptor 125 |
| chr5_-_147211226 | 1.78 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr12_-_91573249 | 1.77 |
ENST00000550099.1
ENST00000546391.1 ENST00000551354.1 |
DCN
|
decorin |
| chr4_+_69962212 | 1.77 |
ENST00000508661.1
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr1_-_144866711 | 1.76 |
ENST00000530130.1
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr10_+_7745232 | 1.75 |
ENST00000358415.4
|
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
| chr3_-_187009646 | 1.74 |
ENST00000296280.6
ENST00000392470.2 ENST00000169293.6 ENST00000439271.1 ENST00000392472.2 ENST00000392475.2 |
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
| chr3_+_35722844 | 1.74 |
ENST00000436702.1
ENST00000438071.1 |
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr3_+_35722424 | 1.73 |
ENST00000396481.2
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr4_+_76995855 | 1.73 |
ENST00000355810.4
ENST00000349321.3 |
ART3
|
ADP-ribosyltransferase 3 |
| chr12_+_111374375 | 1.73 |
ENST00000553177.1
ENST00000548368.1 ENST00000331096.2 ENST00000547607.1 |
RP1-46F2.2
|
RP1-46F2.2 |
| chr17_-_57604227 | 1.72 |
ENST00000584262.1
|
RP11-567L7.6
|
RP11-567L7.6 |
| chr12_-_10978957 | 1.72 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
| chr6_-_84419101 | 1.72 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr12_-_86650077 | 1.72 |
ENST00000552808.2
ENST00000547225.1 |
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
| chr12_+_69202975 | 1.72 |
ENST00000544561.1
ENST00000393410.1 ENST00000299252.4 ENST00000360430.2 ENST00000517852.1 ENST00000545204.1 ENST00000393413.3 ENST00000350057.5 ENST00000348801.2 ENST00000478070.1 |
MDM2
|
MDM2 oncogene, E3 ubiquitin protein ligase |
| chr4_-_65275100 | 1.72 |
ENST00000509536.1
|
TECRL
|
trans-2,3-enoyl-CoA reductase-like |
| chr8_+_19536083 | 1.72 |
ENST00000519803.1
|
RP11-1105O14.1
|
RP11-1105O14.1 |
| chr10_-_99161033 | 1.72 |
ENST00000315563.6
ENST00000370992.4 ENST00000414986.1 |
RRP12
|
ribosomal RNA processing 12 homolog (S. cerevisiae) |
| chrX_-_139866723 | 1.71 |
ENST00000370532.2
|
CDR1
|
cerebellar degeneration-related protein 1, 34kDa |
| chrX_-_15333736 | 1.71 |
ENST00000380470.3
|
ASB11
|
ankyrin repeat and SOCS box containing 11 |
| chr8_-_18744528 | 1.70 |
ENST00000523619.1
|
PSD3
|
pleckstrin and Sec7 domain containing 3 |
| chr5_-_125930929 | 1.70 |
ENST00000553117.1
ENST00000447989.2 ENST00000409134.3 |
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1 |
| chr15_+_71228826 | 1.70 |
ENST00000558456.1
ENST00000560158.2 ENST00000558808.1 ENST00000559806.1 ENST00000559069.1 |
LRRC49
|
leucine rich repeat containing 49 |
| chr7_-_14880892 | 1.70 |
ENST00000406247.3
ENST00000399322.3 ENST00000258767.5 |
DGKB
|
diacylglycerol kinase, beta 90kDa |
| chr8_+_99076509 | 1.68 |
ENST00000318528.3
|
C8orf47
|
chromosome 8 open reading frame 47 |
| chr5_+_140579162 | 1.68 |
ENST00000536699.1
ENST00000354757.3 |
PCDHB11
|
protocadherin beta 11 |
| chr5_-_102898465 | 1.67 |
ENST00000507423.1
ENST00000230792.2 |
NUDT12
|
nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
| chr3_+_156807663 | 1.66 |
ENST00000467995.1
ENST00000474477.1 ENST00000471719.1 |
LINC00881
|
long intergenic non-protein coding RNA 881 |
| chr2_-_100939195 | 1.65 |
ENST00000393437.3
|
LONRF2
|
LON peptidase N-terminal domain and ring finger 2 |
| chr19_-_36643329 | 1.65 |
ENST00000589154.1
|
COX7A1
|
cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) |
| chr20_+_56964169 | 1.64 |
ENST00000475243.1
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C |
| chr8_-_42396185 | 1.63 |
ENST00000518717.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
| chr9_-_19786926 | 1.63 |
ENST00000341998.2
ENST00000286344.3 |
SLC24A2
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 |
| chr12_-_22094336 | 1.63 |
ENST00000326684.4
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
| chr19_-_44388116 | 1.63 |
ENST00000587539.1
|
ZNF404
|
zinc finger protein 404 |
| chr6_+_29624758 | 1.61 |
ENST00000376917.3
ENST00000376902.3 ENST00000533330.2 ENST00000376888.2 |
MOG
|
myelin oligodendrocyte glycoprotein |
| chr14_+_20811766 | 1.61 |
ENST00000250416.5
ENST00000527915.1 |
PARP2
|
poly (ADP-ribose) polymerase 2 |
| chr8_+_120885949 | 1.61 |
ENST00000523492.1
ENST00000286234.5 |
DEPTOR
|
DEP domain containing MTOR-interacting protein |
| chr7_-_121784285 | 1.61 |
ENST00000417368.2
|
AASS
|
aminoadipate-semialdehyde synthase |
| chr12_-_86650154 | 1.61 |
ENST00000552435.2
|
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
| chr4_+_159131630 | 1.61 |
ENST00000504569.1
ENST00000509278.1 ENST00000514558.1 ENST00000503200.1 |
TMEM144
|
transmembrane protein 144 |
| chr1_-_145076186 | 1.60 |
ENST00000369348.3
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr15_-_27018884 | 1.60 |
ENST00000299267.4
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
| chr13_+_111855399 | 1.60 |
ENST00000426768.2
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
| chr20_+_36974759 | 1.60 |
ENST00000217407.2
|
LBP
|
lipopolysaccharide binding protein |
| chr6_-_28303901 | 1.60 |
ENST00000439158.1
ENST00000446474.1 ENST00000414431.1 ENST00000344279.6 ENST00000453745.1 |
ZSCAN31
|
zinc finger and SCAN domain containing 31 |
| chr10_+_53806501 | 1.59 |
ENST00000373975.2
|
PRKG1
|
protein kinase, cGMP-dependent, type I |
| chr16_+_8814563 | 1.58 |
ENST00000425191.2
ENST00000569156.1 |
ABAT
|
4-aminobutyrate aminotransferase |
| chr6_+_153552455 | 1.58 |
ENST00000392385.2
|
AL590867.1
|
Uncharacterized protein; cDNA FLJ59044, highly similar to LINE-1 reverse transcriptase homolog |
| chr7_-_129691201 | 1.58 |
ENST00000480193.1
ENST00000360708.5 ENST00000311873.5 ENST00000481503.1 ENST00000358303.4 |
ZC3HC1
|
zinc finger, C3HC-type containing 1 |
| chr8_+_120079478 | 1.57 |
ENST00000332843.2
|
COLEC10
|
collectin sub-family member 10 (C-type lectin) |
| chr4_+_159131596 | 1.57 |
ENST00000512481.1
|
TMEM144
|
transmembrane protein 144 |
| chr4_-_69536346 | 1.56 |
ENST00000338206.5
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15 |
| chr4_-_70361579 | 1.55 |
ENST00000512583.1
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4 |
| chr19_+_45409011 | 1.54 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
| chr18_+_55862622 | 1.54 |
ENST00000456173.2
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
| chr15_-_45670924 | 1.53 |
ENST00000396659.3
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
| chr2_+_234826016 | 1.53 |
ENST00000324695.4
ENST00000433712.2 |
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8 |
| chr4_-_186732241 | 1.53 |
ENST00000421639.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr22_+_21133469 | 1.53 |
ENST00000406799.1
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
| chr3_+_111717511 | 1.52 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
| chr5_+_140514782 | 1.51 |
ENST00000231134.5
|
PCDHB5
|
protocadherin beta 5 |
| chr4_+_166300084 | 1.51 |
ENST00000402744.4
|
CPE
|
carboxypeptidase E |
| chr6_+_143759575 | 1.51 |
ENST00000595616.1
|
AL031320.1
|
AL031320.1 |
| chr18_-_40857493 | 1.51 |
ENST00000255224.3
|
SYT4
|
synaptotagmin IV |
| chr11_+_65266507 | 1.51 |
ENST00000544868.1
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) |
| chr3_+_145782358 | 1.51 |
ENST00000422482.1
|
AC107021.1
|
HCG1786590; PRO2533; Uncharacterized protein |
| chr5_+_36606700 | 1.50 |
ENST00000416645.2
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr13_+_76413852 | 1.50 |
ENST00000533809.2
|
LMO7
|
LIM domain 7 |
| chrX_+_10126488 | 1.50 |
ENST00000380829.1
ENST00000421085.2 ENST00000454850.1 |
CLCN4
|
chloride channel, voltage-sensitive 4 |
| chr10_-_61900762 | 1.50 |
ENST00000355288.2
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
| chr12_-_54982420 | 1.50 |
ENST00000257905.8
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr15_+_58702742 | 1.49 |
ENST00000356113.6
ENST00000414170.3 |
LIPC
|
lipase, hepatic |
Network of associatons between targets according to the STRING database.
First level regulatory network of BARHL1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 10.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 1.2 | 6.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 1.2 | 4.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 1.1 | 3.4 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 1.1 | 3.4 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 1.1 | 3.3 | GO:0048174 | negative regulation of short-term neuronal synaptic plasticity(GO:0048174) |
| 1.0 | 9.5 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.9 | 11.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.8 | 4.1 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.8 | 4.0 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.8 | 4.7 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.8 | 2.3 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.8 | 0.8 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.7 | 2.2 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.7 | 6.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.7 | 5.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.7 | 2.6 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.6 | 30.6 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.6 | 1.9 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.6 | 9.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.6 | 1.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.6 | 2.9 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
| 0.6 | 1.8 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.6 | 1.7 | GO:1903718 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.6 | 0.6 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 0.6 | 4.0 | GO:0035995 | skeletal muscle myosin thick filament assembly(GO:0030241) detection of muscle stretch(GO:0035995) |
| 0.6 | 2.3 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.6 | 1.7 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.5 | 0.5 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.5 | 0.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.5 | 1.5 | GO:2000646 | lipid transport involved in lipid storage(GO:0010877) positive regulation of receptor catabolic process(GO:2000646) |
| 0.5 | 1.5 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.5 | 1.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.5 | 2.9 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.5 | 2.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.5 | 2.8 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.5 | 1.4 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.5 | 2.3 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.5 | 1.4 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.5 | 1.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.5 | 0.9 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.5 | 1.8 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.4 | 2.7 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.4 | 0.9 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.4 | 0.4 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.4 | 1.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 0.4 | 3.5 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 0.4 | 1.3 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.4 | 9.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.4 | 2.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.4 | 1.7 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.4 | 1.3 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.4 | 3.3 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.4 | 1.6 | GO:0048789 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
| 0.4 | 1.2 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.4 | 2.0 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.4 | 4.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.4 | 3.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.4 | 2.7 | GO:0050955 | thermoception(GO:0050955) |
| 0.4 | 5.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.4 | 1.9 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
| 0.4 | 1.9 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
| 0.4 | 2.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.4 | 1.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 0.4 | 1.1 | GO:0006106 | fumarate metabolic process(GO:0006106) aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
| 0.4 | 1.1 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.3 | 1.0 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.3 | 1.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.3 | 1.4 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.3 | 1.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 | 0.7 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.3 | 1.0 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.3 | 1.4 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.3 | 1.0 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.3 | 5.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.3 | 1.0 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.3 | 1.9 | GO:0046684 | response to pyrethroid(GO:0046684) |
| 0.3 | 0.9 | GO:0046823 | negative regulation of nucleocytoplasmic transport(GO:0046823) |
| 0.3 | 1.9 | GO:0015853 | adenine transport(GO:0015853) |
| 0.3 | 1.2 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.3 | 1.2 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
| 0.3 | 0.6 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.3 | 1.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.3 | 2.1 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.3 | 4.8 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.3 | 0.9 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.3 | 2.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.3 | 1.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
| 0.3 | 1.4 | GO:0030070 | insulin processing(GO:0030070) |
| 0.3 | 4.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.3 | 1.4 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.3 | 4.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.3 | 12.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 | 3.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.3 | 1.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.3 | 0.8 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.3 | 1.9 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.3 | 1.6 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.3 | 11.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.3 | 2.6 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.3 | 2.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 | 1.3 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) operant conditioning(GO:0035106) |
| 0.3 | 1.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.3 | 0.3 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.3 | 1.0 | GO:0034255 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.3 | 1.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 | 0.7 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 0.2 | 0.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.2 | 1.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.2 | 1.0 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.2 | 1.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.2 | 1.0 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.2 | 2.4 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 | 1.7 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.2 | 2.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.2 | 0.7 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.2 | 1.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 | 0.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.2 | 0.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.2 | 0.9 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.2 | 0.5 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.2 | 3.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 | 0.9 | GO:1903770 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.2 | 2.1 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.2 | 1.8 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.2 | 1.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.2 | 0.5 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.2 | 0.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.2 | 2.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
| 0.2 | 4.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.2 | 0.9 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.2 | 0.9 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.2 | 0.7 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.2 | 1.1 | GO:0098907 | protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.2 | 2.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 | 0.9 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.2 | 1.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.2 | 2.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.2 | 4.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.2 | 1.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.2 | 0.9 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.2 | 0.4 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.2 | 3.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.2 | 0.9 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.2 | 4.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.2 | 2.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 | 3.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 | 0.8 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.2 | 0.6 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.2 | 1.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.2 | 1.1 | GO:1902741 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.2 | 0.6 | GO:0018963 | insecticide metabolic process(GO:0017143) dibenzo-p-dioxin metabolic process(GO:0018894) phthalate metabolic process(GO:0018963) |
| 0.2 | 0.8 | GO:0050976 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.2 | 1.0 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.2 | 0.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.2 | 0.6 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.2 | 2.1 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.2 | 15.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 | 1.0 | GO:0009107 | lipoate metabolic process(GO:0009106) lipoate biosynthetic process(GO:0009107) |
| 0.2 | 1.0 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.2 | 2.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 0.8 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.2 | 2.8 | GO:0015705 | iodide transport(GO:0015705) |
| 0.2 | 0.6 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.2 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.2 | 0.8 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.2 | 2.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.2 | 2.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.2 | 1.2 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.2 | 2.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.2 | 0.8 | GO:0072302 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.2 | 1.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.2 | 1.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
| 0.2 | 1.7 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 | 3.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 | 3.8 | GO:0051775 | response to redox state(GO:0051775) |
| 0.2 | 1.3 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 1.7 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.2 | 1.1 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.2 | 3.9 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
| 0.2 | 0.7 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.2 | 1.3 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.2 | 0.6 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.2 | 0.6 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.2 | 0.9 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.2 | 0.9 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.2 | 0.6 | GO:0043060 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 0.2 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.2 | 3.6 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.2 | 3.8 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.2 | 0.5 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.2 | 1.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.2 | 0.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.2 | 0.5 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
| 0.2 | 0.9 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.2 | 0.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.2 | 0.5 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.2 | 1.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 0.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.2 | 0.5 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.2 | 3.7 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.2 | 0.4 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.2 | 3.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 | 1.0 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.2 | 0.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.2 | 0.2 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.2 | 0.7 | GO:0097696 | JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
| 0.2 | 2.2 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.2 | 0.3 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 0.2 | 0.7 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.2 | 1.0 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.2 | 0.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.2 | 0.5 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.2 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 | 5.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.2 | 0.7 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.2 | 0.5 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.2 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.2 | 1.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 | 1.0 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 | 0.7 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.2 | 1.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.2 | 1.1 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.2 | 1.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 | 3.3 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.2 | 0.9 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 0.2 | 1.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 | 0.3 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.2 | 1.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.2 | 0.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.2 | 1.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.2 | 1.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 | 4.5 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.2 | 0.2 | GO:0032213 | regulation of telomere maintenance via semi-conservative replication(GO:0032213) negative regulation of telomere maintenance via semi-conservative replication(GO:0032214) |
| 0.2 | 0.5 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.2 | 0.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.2 | 1.2 | GO:0007405 | neuroblast proliferation(GO:0007405) |
| 0.2 | 1.2 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.2 | 1.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.2 | 2.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 | 1.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 | 0.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 | 0.4 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 0.1 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 | 2.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.1 | 2.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.1 | 2.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
| 0.1 | 0.6 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.1 | 0.3 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 | 0.3 | GO:1990641 | response to iron ion starvation(GO:1990641) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
| 0.1 | 0.4 | GO:1901142 | insulin metabolic process(GO:1901142) |
| 0.1 | 1.0 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 1.0 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 1.3 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 2.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.1 | 0.6 | GO:0048747 | muscle fiber development(GO:0048747) |
| 0.1 | 0.6 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.1 | 2.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 0.7 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 | 7.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.1 | 2.3 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 0.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 1.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.1 | 2.7 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.4 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.1 | 0.5 | GO:0060723 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.1 | 0.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 | 0.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 0.3 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 | 3.6 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 1.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 0.7 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.1 | 1.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.1 | 3.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.1 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 | 2.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.1 | 0.8 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.1 | 1.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.1 | 0.6 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 | 0.6 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 | 1.1 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.1 | 0.1 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.1 | 0.4 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
| 0.1 | 1.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 2.0 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 0.3 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.1 | 0.6 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
| 0.1 | 0.5 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.1 | 0.9 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.1 | 0.5 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 2.1 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 | 0.4 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
| 0.1 | 0.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.1 | 0.9 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 | 2.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 0.6 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.1 | 1.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 | 0.4 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 0.1 | 0.4 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.1 | 2.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 1.0 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.1 | 1.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.1 | 0.7 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.1 | 1.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 1.9 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
| 0.1 | 2.1 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
| 0.1 | 2.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.7 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 0.2 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.1 | 2.0 | GO:0099515 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
| 0.1 | 4.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.1 | 14.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.1 | 2.2 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.1 | 3.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 1.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 | 0.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.1 | 0.7 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.1 | 0.7 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 | 0.5 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.1 | 0.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 | 2.3 | GO:0015865 | purine nucleotide transport(GO:0015865) |
| 0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
| 0.1 | 0.6 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.1 | 0.3 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.1 | 1.5 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 3.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 | 0.3 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 | 0.4 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 | 2.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.4 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.1 | 1.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 | 0.4 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
| 0.1 | 6.9 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.1 | 2.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 0.9 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 1.4 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
| 0.1 | 0.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 | 0.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.1 | 0.6 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.1 | 0.4 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.1 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 0.2 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.1 | 1.7 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 1.2 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 | 0.5 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.1 | 0.4 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
| 0.1 | 1.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 | 0.3 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.1 | 0.3 | GO:0001942 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) skin epidermis development(GO:0098773) |
| 0.1 | 1.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 1.5 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.1 | 0.3 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 2.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.1 | 0.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.1 | 0.3 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.1 | 1.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 0.4 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
| 0.1 | 0.5 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 2.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 | 0.7 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.1 | 1.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.1 | 0.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 | 0.5 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 | 0.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 | 1.9 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
| 0.1 | 0.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 | 1.1 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 | 0.5 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.1 | 0.5 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.1 | 0.3 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.1 | 0.6 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.1 | 4.0 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 0.1 | 1.2 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.8 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.1 | 0.5 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 | 0.5 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
| 0.1 | 0.6 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.1 | 0.2 | GO:0003166 | bundle of His development(GO:0003166) |
| 0.1 | 0.4 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.1 | 0.4 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 | 0.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 | 0.5 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.1 | 1.6 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 1.7 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 | 0.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.8 | GO:0072393 | microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.1 | 0.5 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.1 | 1.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.1 | 1.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 0.8 | GO:1901731 | calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.1 | 0.5 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.1 | 0.3 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 | 0.9 | GO:0060281 | regulation of oocyte development(GO:0060281) regulation of oocyte maturation(GO:1900193) |
| 0.1 | 0.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 0.6 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.1 | 1.2 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 1.0 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.1 | 1.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 0.3 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 | 0.9 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.1 | 0.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.6 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
| 0.1 | 0.2 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.1 | 0.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 0.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.1 | 1.1 | GO:0001501 | skeletal system development(GO:0001501) |
| 0.1 | 0.7 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.1 | 1.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.1 | 1.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 | 1.1 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 | 2.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 2.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 0.6 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.1 | 0.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 | 1.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.1 | 0.5 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 | 0.6 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.1 | 1.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.1 | 0.2 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 | 2.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 1.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 1.7 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 0.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.1 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 2.5 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.4 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 0.7 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.1 | 0.5 | GO:0031179 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.1 | 2.3 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 2.0 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 | 0.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 | 1.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 | 0.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.1 | 0.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 1.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 1.3 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
| 0.1 | 1.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 1.7 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.1 | 0.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 0.3 | GO:0071872 | cellular response to epinephrine stimulus(GO:0071872) |
| 0.1 | 2.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.1 | 0.8 | GO:0048793 | pronephros development(GO:0048793) |
| 0.1 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 | 0.4 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 1.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 1.2 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.1 | 0.4 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 | 0.4 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 1.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 0.4 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.1 | 0.4 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 | 0.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.2 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.1 | 0.6 | GO:0048840 | otolith development(GO:0048840) |
| 0.1 | 0.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.3 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
| 0.1 | 0.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 0.4 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 2.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 0.2 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.1 | 0.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.1 | 1.6 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.1 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) endoplasmic reticulum membrane organization(GO:0090158) |
| 0.1 | 2.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.1 | 1.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.1 | 0.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
| 0.1 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.1 | 0.3 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 | 1.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 0.3 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 | 2.7 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 0.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.1 | 0.6 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 | 0.2 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.1 | 0.3 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.1 | 0.9 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 0.1 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 | 1.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.1 | 3.4 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.1 | 0.5 | GO:0071389 | cellular response to mineralocorticoid stimulus(GO:0071389) |
| 0.1 | 0.5 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 | 4.3 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 4.2 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.1 | 1.9 | GO:0035418 | protein localization to synapse(GO:0035418) |
| 0.1 | 0.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.1 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 0.4 | GO:0014904 | myotube cell development(GO:0014904) |
| 0.1 | 1.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.1 | 1.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.2 | GO:0035568 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 0.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.1 | 0.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.7 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.1 | 0.8 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 | 0.6 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 1.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.1 | 0.8 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.1 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
| 0.1 | 0.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 0.2 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 0.3 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.1 | 1.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 0.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.1 | 0.3 | GO:0051030 | snRNA transport(GO:0051030) snRNA import into nucleus(GO:0061015) |
| 0.1 | 0.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.1 | 0.2 | GO:0051836 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.1 | 0.4 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 | 0.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 0.1 | GO:1903487 | regulation of lactation(GO:1903487) |
| 0.1 | 5.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.1 | 0.2 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 | 1.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.8 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.1 | 0.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 | 0.3 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.1 | 1.0 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.1 | 0.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.2 | GO:0042268 | regulation of cytolysis(GO:0042268) |
| 0.1 | 0.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 | 0.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
| 0.1 | 0.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.1 | 0.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.2 | GO:0055091 | negative regulation of lipoprotein lipase activity(GO:0051005) phospholipid homeostasis(GO:0055091) |
| 0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.1 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 | 0.8 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
| 0.1 | 0.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 0.6 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 1.3 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.1 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.1 | 0.2 | GO:0045188 | optic nerve structural organization(GO:0021633) circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.1 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 1.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.1 | 0.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 | 0.1 | GO:1903336 | intralumenal vesicle formation(GO:0070676) negative regulation of vacuolar transport(GO:1903336) |
| 0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.0 | 0.3 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 | 0.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.0 | 0.4 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.0 | 1.1 | GO:0042755 | eating behavior(GO:0042755) |
| 0.0 | 0.6 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.0 | 0.5 | GO:0043297 | apical junction assembly(GO:0043297) bicellular tight junction assembly(GO:0070830) |
| 0.0 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 1.8 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.0 | 0.9 | GO:0010506 | regulation of autophagy(GO:0010506) |
| 0.0 | 5.7 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.0 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.0 | 0.9 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
| 0.0 | 0.0 | GO:0072422 | signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.0 | 0.7 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
| 0.0 | 2.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |